Sterling Capital Management’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.76M Buy
5,723
+79
+1% +$21K 0.05% 299
2026
Q1
$619K Buy
5,644
+4,742
+526% +$675K 0.01% 671
2025
Q4
$150K Buy
902
+711
+372% +$119K ﹤0.01% 1386
2025
Q3
$37.4K Sell
191
-25
-12% -$4.11K ﹤0.01% 1865
2025
Q2
$19.5K Sell
216
-5,661
-96% -$447K ﹤0.01% 1804
2025
Q1
$351K Sell
5,877
-313
-5% -$29K 0.01% 1015
2024
Q4
$820K Buy
6,190
+5,372
+657% +$504K 0.01% 696
2024
Q3
$42.9K Buy
+818
New +$38.4K ﹤0.01% 1454

Other funds holding ALAB

Sterling Capital Management's ALAB Position: Q2 2026 in Review

Sterling Capital Management increased its Astera Labs (ALAB) stake by 1.4% in Q2 2026, buying an estimated $21K and bringing the position to 5,723 shares worth $2.76M. The position accounts for 0.05% of the portfolio, ranked #299.

Sterling Capital Management first reported a position in ALAB in Q3 2024 and has held it in 8 quarters since. 989 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Sterling Capital Management held 5,723 shares of Astera Labs worth $2.76M as of Q2 2026.
  • Sterling Capital Management bought 79 Astera Labs shares in Q2 2026, an estimated $21K.
  • Astera Labs made up 0.05% of Sterling Capital Management's portfolio in Q2 2026, its #299 holding.
  • Sterling Capital Management first reported a position in Astera Labs in Q3 2024 and has held it in 8 quarters since.
  • 989 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.